📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status. (2019)

First Author: Tweed CD

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12890-019-0907-6

PubMed Identifier: 31412895

Publication URI: http://europepmc.org/abstract/MED/31412895

Type: Journal Article/Review

Volume: 19

Parent Publication: BMC pulmonary medicine

Issue: 1

ISSN: 1471-2466